Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
News & Press Releases
Pharma-Expansion In Africa Necessitates Homegrown Investment
Experts believe that research into diseases that mostly impacts individuals in the region could be the driving force for the development in the pharma sector.
IGBA believes that regulatory authorities can effectively re-evaluate biosimilar access requirements under the modified WHO Biosimilars Guideline for 2022.
Big Pharma May Need To Report State Deals In WHO Crisis
An accord that will encourage pharma companies to disclose their government procurement transactions is being formalized by 194 nations that make up the WHO.
The EMA Endorses Controls On Immune-Regulating Medicines
"There will soon be restrictions placed on use of numerous JAK inhibitors in Europe, particularly among those at high risk for cancer or coronary heart disease.
In Britain, The ABPI Sets Out A Clear Antimicrobial Goal
Modern medicine confronts a major worldwide dilemma because drug-resistant microorganisms are proliferating more speedily than novel antibiotic treatments.
Oxford Scientists Have Found Main Origin of Type 2 Diabetes
Based on the findings of the study, prolonged hyperglycaemia-induced beta-cell failure can be prevented by slowing down pace at which glucose is metabolised.
NHS Should Not Employ 5 COVID Therapies, According To NICE
5 COVID-19 medicines, including antiviral tablet from Merck & Co. for high-risk patients, have been de-recommended by NICE due to cost-effectiveness concerns.
